Connor, Clark & Lunn Investment Management (CC&L)’s Herbalife HLF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.23M Sell
423,269
-188,897
-31% -$3.09M 0.01% 623
2025
Q4
$7.89M Sell
612,166
-258,243
-30% -$2.73M 0.02% 527
2025
Q3
$7.35M Sell
870,409
-143,096
-14% -$1.35M 0.02% 482
2025
Q2
$8.74M Buy
1,013,505
+289,537
+40% +$2.15M 0.03% 429
2025
Q1
$6.25M Buy
723,968
+113,015
+18% +$804K 0.03% 441
2024
Q4
$4.09M Buy
610,953
+60,158
+11% +$447K 0.02% 536
2024
Q3
$3.96M Buy
550,795
+130,818
+31% +$1.2M 0.02% 496
2024
Q2
$4.36M Buy
419,977
+108,707
+35% +$1.09M 0.02% 454
2024
Q1
$3.13M Buy
311,270
+6,263
+2% +$67.3K 0.01% 545
2023
Q4
$4.65M Sell
305,007
-61,255
-17% -$846K 0.02% 441
2023
Q3
$5.12M Buy
366,262
+266,166
+266% +$4.03M 0.03% 392
2023
Q2
$1.33M Buy
100,096
+61,518
+159% +$837K 0.01% 712
2023
Q1
$621K Buy
+38,578
New +$682K ﹤0.01% 828
2022
Q4
Sell
-33,887
Closed -$674K 1305
2022
Q3
$674K Buy
+33,887
New +$839K ﹤0.01% 746
2021
Q1
Sell
-18,771
Closed -$902K 1027
2020
Q4
$902K Sell
18,771
-121,673
-87% -$5.87M 0.01% 648
2020
Q3
$6.55M Buy
140,444
+68,597
+95% +$3.37M 0.04% 265
2020
Q2
$3.23M Sell
71,847
-114,478
-61% -$4.45M 0.02% 374
2020
Q1
$5.43M Buy
186,325
+117,700
+172% +$4.38M 0.05% 231
2019
Q4
$3.27M Sell
68,625
-28,365
-29% -$1.23M 0.02% 339
2019
Q3
$3.67M Buy
96,990
+5,775
+6% +$225K 0.03% 307
2019
Q2
$3.9M Buy
+91,215
New +$4.32M 0.03% 322
2016
Q4
Sell
-30,500
Closed -$945K 928
2016
Q3
$945K Buy
+30,500
New +$963K 0.01% 478
2015
Q3
Sell
-17,800
Closed -$490K 754
2015
Q2
$490K Buy
+17,800
New +$431K ﹤0.01% 428
2014
Q3
Sell
-12,826
Closed -$441K 560
2014
Q2
$441K Sell
12,826
-8,600
-40% -$264K ﹤0.01% 409
2014
Q1
$677K Sell
21,426
-29,200
-58% -$965K 0.01% 439
2013
Q4
$2.12M Buy
+50,626
New +$1.75M 0.02% 255

Other funds holding HLF

Connor, Clark & Lunn Investment Management (CC&L)'s HLF Position: Q1 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) reduced its Herbalife (HLF) stake by 31% in Q1 2026, selling an estimated $3.09M and leaving 423,269 shares worth $6.23M. The position accounts for 0.01% of the portfolio, ranked #623.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in HLF in Q4 2013 and has held it in 26 quarters since. The position peaked at $8.74M in Q2 2025. 252 funds tracked by Wall St. Rank hold HLF as of Q1 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) held 423,269 shares of Herbalife worth $6.23M as of Q1 2026.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 188,897 Herbalife shares in Q1 2026, an estimated $3.09M.
  • Herbalife made up 0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q1 2026, its #623 holding.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Herbalife in Q4 2013 and has held it in 26 quarters since.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Herbalife position peaked at $8.74M in Q2 2025.
  • 252 funds tracked by Wall St. Rank held Herbalife as of Q1 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2026, filed 11 May 2026.